Michael G. Ison, MD MS
Professor of Medicine (Infectious Diseases) and Surgery (Organ Transplantation)
Northwestern University
Chicago, Illinois
Disclosure: Adagio : Consultant (Status: Ongoing); AiCuris () : Grant/Research Support; AlloVir : Consultant (Status: Ongoing); Celltrion () : Consultant; Cidara : Consultant (Status: Ongoing); Genentech () : Advisor or Review Panel member, Consultant, Grant/Research Support; Janssen () : Consultant, Grant/Research Support; Merck : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); SAB Biotherapuetics : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Sequiris : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Shionogi () : Consultant; Shire () : Grant/Research Support; Takeda : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Viracor () : Consultant; Vitaeris : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing)
